SCHEMBL137130

SCHEMBL137130

CCCCCCCCCCC([C]=O)CC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
GPR84 Q9NQS5 5/20 0.40
FDPS P14324 3/20 0.40
FFAR1 O14842 1/20 0.40
LMNA P02545 1/20 0.39
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39
DNM1 Q05193 1/20 0.39
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
LAP3 P28838 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160091 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL9233916 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL6587420 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8648044 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8646134 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL5154559 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8647947 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8647983 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8650122 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL1410679 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024078832-A1 DYE COMPOSITION COMPRISING HENNA AND CELLULASE, AND DYEING METHOD HENKEL AG & CO. KGAA (DE) 2024-04-18 WO claimed
CN-117682912-A Long-acting slow-release water-soluble fertilizer 安阳市喜满地肥业有限责任公司 2024-03-12 CN claimed
EP-3986371-A1 PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND ETHOXYLATED FATTY ALCOHOL Henkel AG & Co. KGaA (DE) 2022-04-27 EP claimed
EP-3986360-A1 PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND A FATTY CONSTITUENT Henkel AG & Co. KGaA (DE) 2022-04-27 EP claimed
US-20210213713-A1 METHOD OF MAKING AN ANTIMICROBIAL MULTILAYER FILM CRYOVAC, LLC 2021-07-15 US claimed
WO-2020254008-A1 PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND ETHOXYLATED FATTY ALCOHOL HENKEL AG & CO. KGAA (DE) 2020-12-24 WO claimed
WO-2020254102-A1 PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND A FATTY CONSTITUENT HENKEL AG & CO. KGAA (DE) 2020-12-24 WO claimed
US-20140322147-A1 ANTIMICROBIAL COMPOSITION UNIV COLUMBIA (US) 2014-10-30 US claimed
WO-2024149491-A1 ORAL CARE COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2024-07-18 WO disclosed
US-12030850-B2 Method for producing ester based on eco-friendly and high-efficiency esterification by using base exchange of salt and the compound thereof WOODWARD BIO CORP. (KR) 2024-07-09 US disclosed
EP-4391991-A1 ORAL COMPOSITIONS AND RELATED METHODS Colgate-Palmolive Company (US) 2024-07-03 EP disclosed
EP-4380360-A1 PRESERVATIVE COMPOSITION Arxada AG (CH) 2024-06-12 EP disclosed
US-20240165001-A1 Oral Compositions and Related Methods COLGATE-PALMOLIVE COMPANY 2024-05-23 US disclosed
WO-2024107944-A1 ORAL COMPOSITIONS AND RELATED METHODS COLGATE-PALMOLIVE COMPANY (US) 2024-05-23 WO disclosed
EP-0604957-B1 2-Amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-09-09 EP disclosed
US-5478809-A Blood disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-12-26 US disclosed
US-5478808-A Blood disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-12-26 US disclosed
EP-0638588-A1 Derivatives of 6,7-Dihydroxy-4-thiaheptonic acid and their use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-15 EP disclosed
EP-0604945-A1 TAN-1511, its derivatives, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-07-06 EP disclosed
EP-0604957-A1 2-Amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-07-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030850-B2 Method for producing ester based on eco-friendly and high-efficiency esterification by using base exchange of salt and the compound thereof SLC6A9, TST, SLC6A5 MAPT 4459/4885GPR84 2560/4885FDPS 1258/4885
US-20240165001-A1 Oral Compositions and Related Methods SOD1, SLC39A7, ZRANB2 MAPT 1117/4885GPR84 3094/4885FDPS 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.